chrysophanic acid has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammar, D; Chang, KC; LaBarbera, DV; Lenhart, P; Li, L; Petrash, JM; Sanborn, TM; Shieh, B | 1 |
| Chu, X; Kong, Q; Liang, R; Sun, R; Wang, L; Xing, C; Zhou, S | 1 |
2 other study(ies) available for chrysophanic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
Topics: Aldehyde Reductase; Aldo-Keto Reductases; Animals; Cataract; Diabetes Complications; Diabetes Mellitus, Experimental; Emodin; Humans; Lens, Crystalline; Mice, Transgenic; Molecular Structure; Oxidative Stress; Structure-Activity Relationship | 2016 |
Chrysophanol Relieves Cognition Deficits and Neuronal Loss Through Inhibition of Inflammation in Diabetic Mice.
Topics: Animals; Anthraquinones; CA3 Region, Hippocampal; Cell Count; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Inflammation; Inflammation Mediators; Male; Maze Learning; Mice; Mice, Inbred ICR; Neurons | 2018 |